CORC

在结果中检索

CORC

浏览/检索结果: 共19条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
A single-arm, multicenter, phase 2 study of camrelizumab in relapsed or refractory classical Hodgkin lymphoma 期刊论文
2019
作者:  Song Yuqin;  Wu Jianqiu;  Chen Xinchuan;  Lin Tong-Yu;  Cao Junning
收藏  |  浏览/下载：27/0  |  提交时间：2020/01/03
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载：33/0  |  提交时间：2020/01/03
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
2019, 卷号: 14, 期号: 5, 页码: 867-875
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 期刊论文
2018, 卷号: 78, 期号: 13
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
CANCER RESEARCH, 2018-07-01
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
BRAIN: A Phase III Trial Comparing WBI and Chemotherapy with Icotinib in NSCLC with Brain Metastases Harboring EGFR Mutations (CTONG 1201) 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S6-S6
作者:  Wu, Yi Long;  Yang, Jin-Ji;  Zhou, Caicun;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
2017, 卷号: 13, 期号: 1, 页码: 87-103
作者:  Shi, Yuankai;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin;  Wang, Ziping
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace